Trisomy 9p syndrome

Trisomy 9p syndrome (also known as duplication 9p, partial trisomy 9p, or 9p trisomy syndrome) is a rare chromosomal disorder characterized by the presence of an extra copy of all or part of the short arm (p) of chromosome 9. This additional genetic material disrupts normal development and leads to a recognizable pattern of physical and developmental abnormalities. The condition was first described in the early 1970s and is one of the more commonly reported autosomal partial trisomies. Key clinical features include intellectual disability of variable severity, characteristic craniofacial dysmorphism such as a globular nose with a rounded tip, downslanting palpebral fissures, deep-set eyes, a short philtrum, downturned corners of the mouth, and malformed or low-set ears. Affected individuals frequently exhibit short stature, brachydactyly (short fingers), clinodactyly (curved fingers), and skeletal anomalies including delayed bone age and scoliosis. Congenital heart defects are reported in a subset of patients. Hypotonia in infancy is common, and psychomotor development is typically delayed. Some individuals may also have seizures and genitourinary anomalies. There is no cure for trisomy 9p syndrome, and management is supportive and symptom-based. Early intervention programs including physical therapy, occupational therapy, and speech therapy are important for optimizing developmental outcomes. Cardiac anomalies may require surgical correction. Regular monitoring by a multidisciplinary team including geneticists, cardiologists, orthopedists, and developmental specialists is recommended. Life expectancy is generally not significantly reduced in the absence of severe congenital malformations, and many individuals survive into adulthood.

Common questions about Trisomy 9p syndrome